Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-111,641
Closed -$80.4K 2649
2025
Q1
$80.4K Hold
111,641
﹤0.01% 2510
2024
Q4
$133K Sell
111,641
-2,900
-3% -$8.12K ﹤0.01% 2414
2024
Q3
$385K Buy
114,541
+103,521
+939% +$456K ﹤0.01% 2023
2024
Q2
$60.1K Sell
11,020
-107,242
-91% -$602K ﹤0.01% 2433
2024
Q1
$627K Buy
118,262
+57,532
+95% +$328K ﹤0.01% 1846
2023
Q4
$383K Buy
+60,730
New +$252K ﹤0.01% 1808
2022
Q2
Sell
-22,334
Closed -$976K 3370
2022
Q1
$976K Buy
+22,334
New +$971K ﹤0.01% 2467
2021
Q4
Sell
-17,849
Closed -$1.1M 3816
2021
Q3
$1.1M Buy
+17,849
New +$1.17M ﹤0.01% 1952

Other funds holding AFMD

Marshall Wace's AFMD Position: Q2 2025 in Review

Marshall Wace sold out of Affimed (AFMD) in Q2 2025, closing a stake of 111,641 shares — an estimated $80.4K sold.

Marshall Wace first reported a position in AFMD in Q3 2021 and held it in 8 quarters. The position peaked at $1.1M in Q3 2021. 3 funds tracked by Wall St. Rank hold AFMD as of Q2 2025.

  • Marshall Wace reported no remaining Affimed position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 111,641 Affimed shares in Q2 2025, an estimated $80.4K.
  • Marshall Wace first reported a position in Affimed in Q3 2021 and held it in 8 quarters.
  • Marshall Wace's Affimed position peaked at $1.1M in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Affimed as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.